✦ LIBER ✦

Phase IIa clinical trial on Alzheimer's disease with NP12, a GSK3 inhibitor

✍ Scribed by Teodoro del Ser

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized, double-blind, par

✍ del Ser, Teodoro; Lovestone, Simon; Boada-Rovira, Mercè; Dubois, Bruno; Hüll, Mi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Rember: Issues in design of a phase 3 di

✍ Claude Wischik 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cerebral microbleeds in a phase 2 clinic

✍ Feldman, Howard; Coric, Vlad; Sperling, Reisa; Greenberg, Steven; Bronen, Richar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Intake of copper has no effect on cognit

✍ Holger Kessler; Thomas A. Bayer; Daniela Bach; Thomas Schneider-Axmann; Tillmann 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 246 KB

Rationale and strategy for thalidomide a

✍ Sabbagh, Marwan N.; Nural, Hikmet; He, Ping; Sirrel, Sherye; Belden, Christine; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety, tolerability and immunogenicity

✍ Arai, Heii; Suzuki, Hideo; Yoshiyama, Tamotsu; Lobello, Kasia; Peng, Yahong; Liu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB